Interferon-induced enhancement of 2',5'-oligoadenylate synthetase in mid-gut carcinoid tumours
- 11 August 1990
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 336 (8711), 337-340
- https://doi.org/10.1016/0140-6736(90)91879-f
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Interferon exerts a cytotoxic effect on primary human myeloma cellsEuropean Journal of Cancer and Clinical Oncology, 1988
- Cytotoxic Treatment in Patients with Malignant Carcinoid Tumors: Response to streptozocin—alone or in combination with 5-FUActa Oncologica, 1987
- Treatment of the Malignant Carcinoid SyndromeThe New England Journal of Medicine, 1986
- Chronic B-lymphocytic leukemia cells proliferate and differentiate following exposure to interferon in vitroBlood, 1986
- Isolation of Daudi Cells with Reduced Sensitivity to Interferon. II. On The Mechanisms of ResistanceJournal of General Virology, 1983
- Isolation and characterization of an interferon-resistant cell line deficient in the induction of (2'-5')oligoadenylate synthetase activity.Molecular and Cellular Biology, 1983
- 2–5A synthetase activity does not increase in interferon-resistant friend leukemia cell variants treated with α/β interferon despite the presence of high-affinity interferon receptor sitesVirology, 1983
- Effects of Interferon on Sensitive and Resistant L1210 Cell Lines.Journal of Interferon Research, 1981
- pppA2'p5'A2'p5'A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells.Proceedings of the National Academy of Sciences of the United States of America, 1978
- Quantitative studies on viral interference in suspended L cellsVirology, 1962